Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.

Journal of thrombosis and haemostasis : JTH - 1 Apr 2016

Nogami K, Ogiwara K, Yada K, Shida Y, Takeyama M, Yaoi H, Minami H, Furukawa S, Hosokawa K, Shima M

Abstract excerpt

BACKGROUND: The clinical phenotype of von Willebrand disease (VWD) is heterogeneous, and von Willebrand factor ristocetin cofactor activity (VWF:RCo) does not always reflect clinical severity, especially in VWD type 1. We have reported the potential of a microchip flow-chamber system (Total-Thrombus Formation Analysis System [T-TAS®]) for assessing physiologic hemostasis in VWD. Aim To evaluate the relationship...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemorrhage
Share to Hemostasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microfluidic Analytical Techniques

Share to Microfluidics

Share to Pressure

Share to Shear Strength

Share to Stress, Mechanical

Share to Thromboplastin

Source

Identifiers

PMID: 27061057
DOI: 10.1111/jth.13273

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.PMID 27061057Read ↗

Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease.Semantic proximity Read ↗

Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.Semantic proximity Read ↗

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.Semantic proximity Read ↗

Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.Semantic proximity Read ↗

The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models.Semantic proximity Read ↗

Smart Clot: An Automated Point-of-Care Flow Assay for Quantitative Whole-Blood Platelet, Fibrin and Thrombus KineticsSemantic proximity Read ↗

Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire.Semantic proximity Read ↗

A mathematical model of flow-mediated coagulation identifies factor V as a modifier of thrombin generation in hemophilia A:Semantic proximity Read ↗

von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.Semantic proximity Read ↗

Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?Semantic proximity Read ↗

Unfolded Von Willebrand Factor Binds Protein S and Reduces Anticoagulant ActivitySemantic proximity Read ↗

Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.